Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients

ClinicalTrials.gov ID: NCT01489969

Public ClinicalTrials.gov record NCT01489969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 17, 2026, 4:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Parallel Group, Randomized, Placebo Controlled Sleep Laboratory Study of Efficacy and Safety of Neu-P11 in Insomnia Patients Aged 18-80

Study identification

NCT ID: NCT01489969
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Neurim Pharmaceuticals Ltd.; Industry
Enrollment: 137 participants

Conditions and interventions

Conditions

Primary Insomnia

Interventions

Neu-P11 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2011
Primary completion: Apr 30, 2012
Completion: Dec 31, 2012
Last update posted: Jun 5, 2018

2011 – 2013

United States locations

U.S. sites: 9
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Pacific Research Network	San Diego	California	92103	—
MD Clinical	Hallandale	Florida	33009	—
Miami research Associates	South Miami	Florida	33143	—
Sleep Disorders Centers of Georgia	Atlanta	Georgia	30342	—
Chicago Research Center	Chicago	Illinois	60634	—
Vince & Associates Clinical Research	Overland Park	Kansas	66212	—
Community Research and Sleep Management	Crestview Hills	Kentucky	41017	—
Center for Sleep and Wake Disorders	Chevy Chase	Maryland	20815	—
Clinilabs, Inc.	New York	New York	10119	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01489969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 5, 2018 · Synced May 17, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01489969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →